MHTP Technology Platform Review

MHTP Technology Platforms are an integral component of the MHTP research strategy, providing cutting edge capabilities and expertise to support research within the Precinct. Each Platform recently underwent a review to ensure alignment with current research resulting in several rationalisation strategies.

During the review, Hudson Institute Centre Heads were invited to provide feedback, and the process was also raised at the last Group Heads meeting. Following consideration and incorporation of feedback, actions have now been endorsed by executive management of Hudson Institute and Monash SCS.

The following changes to services will take affect in early 2019

• Sanger Sequencing, Fragment Analysis, Microarray and Cell Line ID services will cease on Sunday, 31 March 2019. This primarily stems from Life Technologies and Agilent's decision to no longer support the ageing model of instruments (our 3130xl will be 14 years old and Scanner, 16 years old). Monash University's Micromon service can provide internal pricing, so there will be minimum change in charges. Turn around time will be 48 hours for sequencing and electrophoresis and transport arranged are presently being confirmed.

• Quantstudio 6 (low throughput qPCR) services will be merged with the BioMark (high throughput qPCR) service by Sunday, 31 March 2019. The BioMark instrument will operate under a 'Do-It-Yourself' access mode following training and induction (ie; in line with use of the current Quantstudio 6 systems). Real Time PCR reagents will be purchased through the Hudson Institute store via the intranet page (Bio Bars form) as of Thursday, 3 January 2019 and not available through the Platform.

• Diagnostic Mass Spectrometry capabilities will be relocated to Monash Pathology by Sunday, 31 March 2019. Remembering, Hudson Institute has a subscription to access instruments in Bio21 and support through the Monash Biomedical Proteomics Facility is also available.

Please do not hesitate to contact me should you require any further information.

Thank you for your continuous support of the MHTP Technology Platforms and look forward to advancing capabilities to support your research in the new year.

Kind regards

Vivien Vasic

MHTP Platform Strategic Initiatives Manager 
MHTP Medical Genomics Facility Manager
Monash Health Translation Precinct
C/o Hudson Institute of Medical Research
27-31 Wright Street, Clayton VIC 3168

Tel:   +61 3 8572 2770 (office)
Tel:   +61 3 9902 4790 (lab)
Mob: 0407 309 833
Fax:   +61 3 9594 7111

Website: http://www.mhtpmedicalgenomics.org.au/    www.hudson.org.au
Email:     Vivien.Vasic@hudson.org.au